Content
02/25/2025
Copenhagen Denmark
About
FuseVectors is a biotech start-up revolutionizing gene therapy with its cell-free viral vector technology. Traditional AAV development relies on cell-based methods, which are poorly controlled, leading to variable purity and reduced therapeutic efficacy and safety. Fuse Vectors’ cell-free technology combines component module libraries with on-demand biocatalytic AAV capsid filling processes. This eliminates cell-based production and offers significant improvements, reducing production time and costs while enhancing vector quality to meet patients unmet needs.
Startup
Sector:
Biotech
Life Science
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
